These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7266969

  • 21. Tamoxifen and endometrial cancer: tamoxifen effects on the human female genital tract.
    Cohen CJ.
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-55-S1-64. PubMed ID: 9045317
    [Abstract] [Full Text] [Related]

  • 22. [Vaginal oestrogen therapy in women with hormone-sensitive breast cancer].
    Bak AM, Laursen BE, Rungby J, Brock B.
    Ugeskr Laeger; 2011 Feb 28; 173(9):648-51. PubMed ID: 21362392
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Estrogenic action of cardiac glycosides. Clinical and animal experiment studies].
    Hofmann P, Häffele R, Buchholz C.
    Fortschr Med; 1975 Sep 25; 93(27):1274-6. PubMed ID: 1241381
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.
    Rutanen EM, Heikkinen J, Halonen K, Komi J, Lammintausta R, Ylikorkala O.
    Menopause; 2003 Sep 25; 10(5):433-9. PubMed ID: 14501605
    [Abstract] [Full Text] [Related]

  • 31. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M, Moro C, Ferretti G, Calabro MG, Nolè F, Rocca A, Munzone E, Castro A, Curigliano G.
    Anticancer Res; 2001 Sep 25; 21(1B):585-8. PubMed ID: 11299809
    [Abstract] [Full Text] [Related]

  • 32. Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.
    Roberts CG, Millar EK, O'Toole SA, McNeil CM, Lehrbach GM, Pinese M, Tobelmann P, McCloy RA, Musgrove EA, Sutherland RL, Butt AJ.
    Oncogene; 2011 Jul 14; 30(28):3186-97. PubMed ID: 21383694
    [Abstract] [Full Text] [Related]

  • 33. Metabolic effects of tamoxifen in postmenopause.
    Sismondi P, Biglia N, Giai M, Sgro L, Campagnoli C.
    Anticancer Res; 1994 Jul 14; 14(5B):2237-44. PubMed ID: 7840529
    [Abstract] [Full Text] [Related]

  • 34. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
    Novoa Vargas A, Font López KC, Amador DD.
    Ginecol Obstet Mex; 2011 Sep 14; 79(9):553-7. PubMed ID: 21966856
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.
    Unkila M, Kari S, Yatkin E, Lammintausta R.
    J Steroid Biochem Mol Biol; 2013 Nov 14; 138():107-15. PubMed ID: 23665515
    [Abstract] [Full Text] [Related]

  • 40. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
    Lim YC, Desta Z, Flockhart DA, Skaar TC.
    Cancer Chemother Pharmacol; 2005 May 14; 55(5):471-8. PubMed ID: 15685451
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.